Skip to main content
. 2020 May 19;11:950. doi: 10.3389/fimmu.2020.00950

Figure 2.

Figure 2

Anti-CD25 depletion of H. bakeri- induced Tregs does not affect reduction of LN hyperplasia after DBP-FITC challenge. (A) Timeline of DBP-FITC topical application model including treatment with anti-CD25 or isotype control. (B) Frequency of FoxP3+ CD25+ cells within the CD4+ T cell compartment at day 7 in the ear dLN. (C) Total number of live CD45+ cells from the ear dLN at day 7. (D) Relative difference in ear thickness at day 7 after DBP-FITC challenge in mice with or without Hb infection, treated with anti-CD25 or an isotype control. A one-way ANOVA with Tuckey's multiple comparisons test was used to test statistical significance. Graphs represent data combined from 2 experiments and show mean ± SD. n.s, not significant; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.